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Left ventricular clefts – incidental finding or
pathologic sign of Wilson’s disease?
Kun Zhang1,2,6* , Ulrike Reuner3, Marie Weidauer4, Uwe Speiser4, Karim Ibrahim5, Marian Christoph5,
Frank R. Heinzel1,6, Burkert Pieske1,2,6, Felix M. Heidrich4 and Silvio Quick5
Abstract
Background: Wilson’s disease is an inherited autosomal recessive multi-systemic disorder characterized by reduced
excretion and consequently excessive accumulation of copper in different organs, such as the heart.
Results: In a prospective controlled trial, which is the largest to date, we evaluated 61 patients with Wilson’s
disease, age- and sex-matched to 61 healthy patients, for cardiac manifestation using cardiac magnetic resonance
imaging. Patients were under stable disease and had no signs of heart failure at the time of examination.
We detected a left ventricular cleft, an invagination penetrating more than 50% wall thickness of the adjoining
compact myocardium in diastole, in 20% of the patients (12 out of 61) compared to 5% among control patients (3
out of 61, p = 0.013). No correlation between the incidence of cleft and a certain genotype of Wilson’s disease was
found. All described cases were incidental findings and none of the patients showed other signs of cardiac
involvement.
Conclusions: To conclude, the results of this study suggests that the increased occurrence of left ventricular clefts
is due to Wilson’s disease. Large studies with a long observation period are needed for further evaluation.
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Wilson’s disease is an inherited autosomal recessive
multi-systemic disorder characterized by reduced excre-
tion and consequently excessive accumulation of copper
in different organs. Cardiac involvement has been con-
sidered to be benign in the past. However, cases of car-
diac sudden death and an increased incidence of
arrhythmias and heart failure have been reported. Just
recently, we have demonstrated that even asymptomatic
patients exhibit structural disease and autonomic dys-
function of the heart [1, 2].
In a prospective controlled trial, which is the largest to
date, we evaluated 61 patients with Wilson’s disease for
cardiac manifestation. Wilson’s disease was diagnosed
beforehand by hepatic copper content assessment in
liver biopsy specimens and laboratory findings (cerulo-
plasmin level in serum below the limit of normal and 24
h high urinary copper excretion > 100 μg/d). Patients
were under stable disease and had no signs of heart fail-
ure at the time of examination. All patients underwent
cardiac magnetic resonance imaging (cMRI) and were
age- and sex-matched to 61 healthy patients.
Intriguingly, we detected a left ventricular cleft, an in-
vagination penetrating more than 50% wall thickness of
the adjoining compact myocardium in diastole, in 20%
of the patients (12 out of 61) compared to 5% among
control patients (3 out of 61, p = 0.013). Left ventricular
clefts became best visible in the late gadolinium en-
hancement images and cine sequences in cMRI (Fig. 1,
Additional file 1: Video S1). They were located in the
septal segments (3 out of 12), the inferior (4 out of 12),
the lateral (3 out of 12) and the anterior wall (2 out of
12). Additionally, real-time 3D contrast echocardiog-
raphy was performed, in which an interventricular shunt
could be excluded. No correlation between the incidence
of cleft and a certain genotype of Wilson’s disease was
found (Table 1).
Myocardial clefts are congenital abnormalities related
to myocardial fiber or fascicle disarray. Congenital
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myocardial clefts or fissures are commonly seen in the
basal inferior wall of the left ventricle and the mid to ap-
ical segments of the interventricular septum. Petryka
et al. studied 686 patients and found these clefts (also
called crypts) to be most prevalent in patients with
hypertrophic cardiomyopathy (15.6%), myocarditis
(15.3%), and arterial hypertension (13.6%). Clefts were
also evident, albeit significantly fewer, in 6.7% of the
healthy patients [3]. In other studies, the incidence of
clefts in hypertrophic cardiomyopathy was even higher
with 61 and 81%, respectively [4, 5]. They were proposed
to be a prephenotypic marker of hypertrophic cardiomy-
opathy, that means representing early signs of myocar-
dial alterations in patients that carry a gene defect who
have not displayed the phenotype yet. The high variance
in prevalence among different studies may be due to the
variability of cMRI procedures and the interpretation
thereof.
The results of our study suggest that clefts are due to
the pathology of Wilson’s disease. All described cases
were incidental findings and none of the patients showed
other signs of cardiac involvement. The etiology is a
matter of speculation. One hypothesis regarding the
pathophysiological mechanism of cleft formation was de-
scribed by Moon and McKenna who speculate that they
may represent a sign of abnormal fetal cardiomorpho-
genesis [5]. However, it remains unknown how patho-
logical accumulations of copper could support this
theory and cause them.
Left ventricular clefts have not been associated to Wil-
son’s disease before. Previous imaging studies on cardiac
manifestation are mainly echocardiography based and
have not reported on clefts so far. Likewise, in none of
our 12 patients, echocardiography was able to detect any
evidence thereof. Echocardiographic visualization can be
challenging, particularly if cleft location does not coin-
cide with standard acquisition planes. Therefore, cMRI
seems to be more sensitive in detecting structural abnor-
malities than routine echocardiography.
To conclude, the results of this study suggests the
occurrence of left ventricular clefts in cMRI as an
early sign of Wilson’s disease in the heart. Large stud-
ies with a long observation period are needed for
validation. We propose that patients with Wilson’s
disease receive cMRI as a standard tool to evaluate
cardiac manifestation, specifically with a careful
search for left ventricular clefts.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13023-019-1238-7.
Additional file 1: Video S1. Video showing interventricular cleft.
Fig. 1 Representative cardiac magnetic resonance images revealing
left ventricular clefts. Late gadolinium enhancement images (a and
c) and cine sequences (b and d) of two patients with Wilson’s
disease. The arrows show a deep left ventricular cleft in the
interventricular septum (patient 1, upper row) and in the anterior
wall (patient 2, lower row). LV - left ventricle, RV - right ventricle
Table 1 Chi-quadrat analysis of Wilson’s disease mutations and
left ventricular clefts
Mutation nm nc p-value
H1069Q 24 6 0.39
A1135Q 7 2 0.53
Q1351Stop 5 1 0.98
M769 V 1 1 –
R969Q 2 2 –
P1352S 2 – –
M769H 5 – –
R1041W 2 – –
S105Stop 2 – –
D765N 2 – –
H643I 1 – –
Q111Stop 1 – –
V845S 1 – –
G1266R 1 – –
P1273L 1 – –
G1061E 1 – –
T1434 M 1 – –
L1325R 1 – –
V1282C 1 – –
Nm number of patients with an underlying mutation for Wilson’s disease, nc
number of patients with left ventricular clefts
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